Furthermore, we demonstrated that alteplase showed HT and/or ICH signals when administered in combination with the antiplatelets aspirin, P2Y12 inhibitors, cilostazol, or ozagrel sodium (Table 1). This evidence concerns the gene P2RY12 and hematocrit.